Copy number variations of E2F1: a new genetic risk factor for testicular cancer

This study suggests for the first time an involvement of E2F1 CNVs in TGCT susceptibility and supports previous preliminary data on the importance of AKT/mTOR signaling pathway in this cancer.

Source: Endocrine-Related Cancer - February 14, 2017 Category: Endocrinology Authors: Rocca, M. S., Di Nisio, A., Marchiori, A., Ghezzi, M., Opocher, G., Foresta, C., Ferlin, A. Tags: Research Source Type: research